Book a demo
Topics · AI-CONTROL-PLANE

Healthcare Payors AI Gateway Build vs Buy | Moring

For healthcare payors, the build-versus-buy decision for an AI gateway hinges on where scarce engineering capacity should go: the enforcement point itself, or the payor-specific controls that ride on it. Commercial and open-source gateways already centralize authentication, routing, budgets, and observability, so building from scratch rarely pays, while buying still leaves configuration of identity, approvals, and audit evidence in payor hands.

On this page
  1. Short answer
  2. How it works
  3. FAQs
  4. Related reading
  5. Sources

Short answer

For healthcare payors, the build-versus-buy decision for an AI gateway hinges on where scarce engineering capacity should go: the enforcement point itself, or the payor-specific controls that ride on it. Commercial and open-source gateways already centralize authentication, routing, budgets, and observability, so building from scratch rarely pays, while buying still leaves configuration of identity, approvals, and audit evidence in payor hands.

How it works

The build-versus-buy question for a healthcare payor is best framed by what the gateway category has already commoditized. Market analysis of AI gateways in 2026 describes a category that began as a shared proxy for authentication, model routing, rate limits, cost control, and observability, and is now extending control beyond model requests to tools, APIs, and agents. Core proxy capabilities exist in offerings from major platform vendors and open-source projects, which means a payor that builds its own gateway is largely reimplementing solved infrastructure while its claims, prior authorization, and member-service agents wait.

What a payor cannot buy off the shelf is the mapping between gateway capabilities and payor-specific obligations. Enterprise research from HIMSS finds healthcare organizations evaluating how to source AI capabilities, structure governance and oversight, and integrate them into clinical and operational environments, with buy-versus-build factors and vendor selection varying across global regions. The gateway itself is generic; the identity model for delegated agent access, the approval gates on consequential writes, and the audit evidence format that internal audit expects are payor decisions that no vendor makes for you.

Scale considerations favor buying the plumbing and building the policy layer. Survey data cited in gateway market analysis reports that 62 percent of organizations were at least experimenting with agents and 23 percent were scaling one somewhere in the enterprise, while only 21 percent had a mature agentic-AI governance model. A payor in that gap between adoption and governance maturity should spend its engineering time on enforcement depth, such as per-use-case budgets for claims workloads and human override paths for member-facing actions, rather than on maintaining provider adapters.

The hybrid path deserves explicit attention. Gateway architectures are modular: a payor can adopt a commercial or open-source gateway for traffic handling and integrate its own external processing service for the controls that differentiate it, such as payor-specific policy checks, escalation routing, or evidence export into existing audit infrastructure. This preserves the option to replace the underlying gateway without rewriting governance, an important hedge given how quickly the category is evolving from model proxy to agent enforcement point.

Due diligence differs by path. Buying shifts implementation risk to a vendor but introduces concentration and roadmap questions that procurement must test against payor deployment constraints, including where traffic may flow and whether deployment can run inside the payor boundary. Building retains control and data locality but transfers maintenance burden to internal teams indefinitely. Either way, the decision should be tested against a concrete pilot: route one governed workload, such as a prior authorization agent, through the candidate gateway and verify identity propagation, budget enforcement, and log export under real traffic.

The deciding principle is that the gateway is a means, not the product. A payor does not differentiate on proxy latency or credential rotation; it differentiates on how quickly it can deploy a new governed agent into production with evidence attached. Choose the sourcing model that minimizes time from policy decision to enforced behavior, and revisit it at defined milestones as both the gateway market and the payor's agent portfolio mature.

Frequently asked questions

Why should a healthcare payor generally avoid building a gateway from scratch?

The AI gateway category has commoditized its core: authentication, model routing, rate limits, cost control, and observability are standard across commercial and open-source offerings, and vendors are already extending control to tools and agents. A payor building its own proxy would spend scarce engineering capacity reproducing solved infrastructure. The differentiating work, payor-specific policy, approvals, and audit evidence, sits above the gateway and can be built on either sourcing choice.

What payor-specific work remains after buying a gateway?

Buying the plumbing leaves the governance substance to the payor: defining agent identities and delegated access, setting approval gates on consequential actions such as claim adjustments, scoping budgets to claims, care management, and member service, and exporting gateway logs into the audit formats internal review expects. Market analysis of 2026 gateways emphasizes that request-level controls alone are insufficient; the payor must connect the AI gateway to its own accountability structure.

How should a payor evaluate gateway vendors during procurement?

Test candidates against a concrete pilot rather than feature lists. Route one governed workload, for example a prior authorization agent, through each option and verify that caller identity propagates end to end, that budget and policy enforcement behaves under load, and that logs export cleanly into existing audit tooling. Procurement should also probe deployment boundaries, since payors need clarity on where request and response traffic may flow before protected health information is involved. Enforcement at the AI gateway is what makes this hold in practice.

Is a hybrid build-and-buy approach realistic for payors?

Yes, and it is often the pragmatic answer. AI gateway architectures include extension points that let an external service inspect and modify traffic, so a payor can adopt a maintained gateway for traffic handling while implementing custom checks for its own policy logic and evidence export. This keeps the organization free to swap the underlying gateway later without rewriting governance, which matters in a market evolving as quickly as AI infrastructure currently is.

Sources

  1. www.spencerfane.com
  2. www.tactionsoft.com
  3. www.himss.org
  4. wilcosource.com
  5. www.scalekit.com
  6. mastechdigital.com
  7. www.aklivity.io
  8. www.tigera.io
  9. - artificialintelligenceact.eu